PharmiWeb1d
PLL Therapeutics obtains authorization to start phase I/II trial in Australia for patients with Amyotrophic Lateral Sclerosis (ALS)
today announces it will start a phase I/II clinical study in Australia for patients with Amyotrophic Lateral Sclerosis (ALS). The launch of this ALS study follows the recent approval by the Australian ...
Eisai: Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin for Injection25 mg" (mecobalamin) has been launched in Japan as ...
Woman Given Weeks to Live Gets Christmas Early Thanks to Community: 'We Had to Do This'
A Virginia community has brought Christmas early to a woman with amyotrophic lateral sclerosis (ALS), who has just weeks to ...
Stockhead on MSN1d
Preclinical studies confirm potential of Neurizon’s lead drug to treat ALS
Special Report: Clinical-stage biotech Neurizon Therapeutics has released positive results of preclinical studies confirming ...
Finanznachrichten22h
Neurizon Therapeutics Limited: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) Neurizon's lead drug NUZ-001 and its major active metabolite significantly and ...
Woman, 29, Discovers Through Genetic Testing She Will One Day Develop ALS: 'Don't Really Think It's Hit Me Yet' (Exclusive)
Lee Wilson discovered she has a "100%" chance of developing ALS, after losing her father and grandmother to the disease ...
FierceBiotech7d
Third Rock-backed Trace uses $101M series A to go after same ALS target as Lilly
Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.
Want to speak Italian? Microsoft AI can make it sound like you do.
A new AI-powered interpreter is expected to simulate speakers’ voices in different languages during Microsoft Teams meetings.
News Medical on MSN4d
Largest ALS patient-based iPSC repository opens new frontiers in research
In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, ultimately leading to muscle weakness and paralysis. ALS is an orphan disease, but its ...